Table 2.
Outcomes of the included studies
| First author | Bart | Bart | Hanna | Giglioli | Seker | Costanzo | Marenzi | Costanzo |
|---|---|---|---|---|---|---|---|---|
| Year | 2005 | 2012 | 2012 | 2011 | 2016 | 2007 | 2014 | 2015 |
| Intervention group size | 20 | 94 | 17 | 15 | 10 | 100 | 27 | 110 |
| Control group size | 20 | 94 | 19 | 15 | 20 | 100 | 29 | 111 |
| Worsening HF in UF group | 31 | 2 | 39 | 4 | ||||
| Worsening HF in UC group | 28 | 7 | 63 | 3 | ||||
| Renal impairment in UF group | 17 | 8 | 2 | 21 | 2 | |||
| Renal impairment in UC group | 14 | 6 | 1 | 17 | 2 | |||
| Rehospitalization for HF in UF group | 23 | 16 | 1 | 10 | ||||
| Rehospitalization for HF in UC group | 24 | 28 | 14 | 22 | ||||
| Deaths in UF group | 1 | 16 | 4 | 4 | 9 | 7 | 17 | |
| Deaths in UC group | 0 | 13 | 4 | 2 | 11 | 11 | 14 | |
| Weight loss in UF group (kg) | 2.5 | 5.7 ± 3.9 | 4.7 ± 3.5 | 5.0 ± 3.1 | 7.5 ± 5.5 | 10.7 ± 7.2 | ||
| Weight loss in UC group (kg) | 1.86 | 5.5 ± 5.1 | 1.0 ± 2.5 | 3.1 ± 0.75 | 7.9 ± 9.0 | 10.3 ± 9.2 | ||
| Fluid removal in UF group (mL) | 8415 | 7443 ± 4329 | 5215 ± 3406 | 11086 ± 1786 | 7872 ± 1829 | 4600 ± 2600 | 12900 | |
| Fluid removal in UC group (mL) | 5375 | 7082 ± 4183 | 2167 ± 2380 | 10425 ± 3002 | 6882 ± 4221 | 3300 ± 2600 | 8900 | |
| UF – ultrafiltration, UC – usual care, AE – adverse events, RCT – randomized controlled trial, DM – diabetes mellitus, ACE – angiotensin-converting enzyme inhibitor, ARB – angiotensin II receptor blocker | ||||||||